We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Italian Consortium Acquires Esaote

By HospiMedica staff writers
Posted on 31 Jan 2006
Banca Intesa (Milan, Italy) and the Bracco Group (Milan, Italy), a global leader in diagnostic imaging, have agreed to the sale of Esaote SpA (Genova, Italy) to a consortium of investors led by Banca Intesa, including Prof. Carlo Castellano, current chairman and CEO of Esaote.

The transaction is part of Banca Intesa's strategy to sustain Italy's development by supporting entrepreneurs who invest in innovation and long-term growth by the acquisition of equity stakes. The sale of Esaote stems from a precise strategic decision for the Bracco Group headed by Diana Bracco: on the one hand, to focus on the development of new proprietary systems with a cutting-edge innovation content in the sector of diagnostics and targeted therapy; on the other hand, to further increase its competitive capacities on the global international markets in which Bracco competes.

Esaote, with a consolidated turnover exceeding 240 million euros--of which approximately 60% was generated in international markets--is the leader in Italy in the sector of biomedical appliances (specifically, ultrasound, targeted magnetic resonance [MR], and software to manage the diagnostic process). Esaote has its industrial and research units in Italy and the Netherlands, and in 2004 established a joint venture in China for the production of ecographic equipment, in which it has an 80% stake.

Corrado Passera, managing director and CEO of Banca Intesa SpA, commented, "Esaote is an extremely successful industrial and technological entity in the Italian research panorama. One of Banca Intesa's missions is to sustain Italian companies which are sound from an industrial standpoint, have considerable technological competencies, and are significant in terms of employment.”

Diana Bracco, chairman and managing director of Bracco SpA stated, "Over the years, the Bracco group has become the sole Italian global player in the sector of contrast methods for diagnostic imaging with market shares which are, on average, about 30% in the United States and Germany, and close to 50% in Italy and Japan.”




Related Links:
Banca Intesa
Bracco
Esaote
Ultrasound Needle Guidance System
SonoSite L25
Portable X-ray Unit
AJEX140H
Mobile X-Ray System
K4W
Breast Localization System
MAMMOREP LOOP

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.